Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma
跨队列分析确定了一种基于免疫检查点的特征,可用于预测神经母细胞瘤的临床结局。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-005980
Zeng, Liang; Xu, Hui; Li, Shu-Hua; Xu, Shuo-Yu; Chen, Kai; Qin, Liang-Jun; Miao, Lei; Wang, Fang; Deng, Ling; Wang, Feng-Hua; Li, Le; Fu, Sha; Liu, Na; Wang, Ran; Li, Ying-Qing; Wang, Hai-Yun